Cite
HARVARD Citation
Krauter, J. et al. (2018). Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial). British journal of haematology. pp. 235-241. [Online].